ICU Medical, Inc. (ICUI) has 20 known insider and institutional holders on record. The largest holder is SMITHS GROUP PLC with 1,670,000 shares. Other notable holders include Smiths Group International Holdings Ltd and LOPEZ GEORGE A.
Over the last 12 months, insiders have made 44 transactions in ICUI stock — 2 buys (valued at $342.55K) and 14 sells (valued at $7.35M). Insider selling has exceeded buying during this period.
ICUI Insider Ownership
Top Holder
SMITHS GROUP PLC
1,670,000 shares
Buys (12 mo)
2
$342.55K value
Sells (12 mo)
14
$7.35M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Smiths Group Plc |
Other: Former 10% Owner |
1,670,000 |
2024-03-01 |
|
| 2 |
Smiths Group International Holdings Ltd |
Other: Former 10% Owner |
1,670,000 |
2024-03-01 |
|
| 3 |
Lopez George A |
Director |
885,321 |
2024-03-14 |
|
| 4 |
Swinney Robert S |
Director |
20,816 |
2021-09-15 |
|
| 5 |
Jain Vivek |
Chairman and CEO |
10,566 |
2026-03-09 |
|
| 6 |
Greenberg David C. |
Director |
7,362 |
2025-08-27 |
|
| 7 |
Voigtlander Christian B. |
Chief Operating Officer |
7,044 |
2026-03-09 |
|
| 8 |
Bonnell Brian Michael |
Chief Financial Officer |
7,044 |
2026-03-09 |
|
| 9 |
Sanzone Virginia Ruth |
VP, General Counsel |
6,507 |
2026-03-09 |
|
| 10 |
Abbey Donald |
Director |
4,046 |
2026-03-26 |
|
| 11 |
Mcgrody Kevin J |
Chief Accounting Officer |
4,027 |
2022-03-08 |
|
| 12 |
Finney Elisha W |
Director |
3,252 |
2025-05-20 |
|
| 13 |
Woolson Daniel |
VP, GM-infusion Capital |
3,170 |
2026-03-09 |
|
| 14 |
Sousa Ben |
Chief Information Officer |
1,106 |
2026-03-09 |
|
| 15 |
Lamb Scott E |
Chief Financial Officer, |
1,005 |
2020-02-14 |
|
| 16 |
Burcar Alison D |
Vice President and Gen'l Mgr. |
512 |
2019-03-28 |
|
| 17 |
Kennedy Kolleen T |
Director |
485 |
2022-05-18 |
|
| 18 |
Hernandez Laurie |
Director |
485 |
2022-05-18 |
|
| 19 |
Hoffmeister David F |
Director |
485 |
2022-05-18 |
|
| 20 |
Mccall Thomas D |
Vice President and Gen'l Mgr. |
351 |
2019-03-28 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-25 |
Abbey Donald |
Director |
Other (Sell) |
704 |
- |
- |
| 2026-03-15 |
Sousa Ben |
Chief Information Officer |
Option Exercise (Sell) |
1,300 |
- |
- |
| 2026-03-15 |
Bonnell Brian Michael |
Chief Financial Officer |
Option Exercise (Sell) |
11,400 |
- |
- |
| 2026-03-15 |
Voigtlander Christian B. |
Chief Operating Officer |
Option Exercise (Sell) |
11,400 |
- |
- |
| 2026-03-15 |
Woolson Daniel |
VP, GM-infusion Capital |
Option Exercise (Sell) |
2,924 |
- |
- |
| 2026-03-15 |
Sanzone Virginia Ruth |
VP, General Counsel |
Option Exercise (Sell) |
1,624 |
- |
- |
| 2026-03-15 |
Jain Vivek |
Chairman and CEO |
Option Exercise (Sell) |
17,100 |
- |
- |
| 2026-03-08 |
Sousa Ben |
Chief Information Officer |
Option Exercise (Sell) |
7,177 |
- |
- |
| 2026-03-07 |
Sousa Ben |
Chief Information Officer |
Tax Withholding of RSU |
782 |
$132.00 |
$103.22K |
| 2026-03-08 |
Bonnell Brian Michael |
Chief Financial Officer |
Option Exercise (Sell) |
71,757 |
- |
- |
| 2026-03-07 |
Bonnell Brian Michael |
Chief Financial Officer |
Option Exercise (Sell) |
3,522 |
- |
- |
| 2026-03-08 |
Voigtlander Christian B. |
Chief Operating Officer |
Option Exercise (Sell) |
71,757 |
- |
- |
| 2026-03-07 |
Voigtlander Christian B. |
Chief Operating Officer |
Option Exercise (Sell) |
3,522 |
- |
- |
| 2026-03-08 |
Woolson Daniel |
VP, GM-infusion Capital |
Option Exercise (Sell) |
16,147 |
- |
- |
| 2026-03-07 |
Woolson Daniel |
VP, GM-infusion Capital |
Option Exercise (Sell) |
1,585 |
- |
- |
| 2026-03-08 |
Sanzone Virginia Ruth |
VP, General Counsel |
Option Exercise (Sell) |
23,917 |
- |
- |
| 2026-03-07 |
Sanzone Virginia Ruth |
VP, General Counsel |
Tax Withholding of RSU |
1,297 |
$132.00 |
$171.2K |
| 2026-03-08 |
Jain Vivek |
Chairman and CEO |
Option Exercise (Sell) |
107,635 |
- |
- |
| 2026-03-07 |
Jain Vivek |
Chairman and CEO |
Option Exercise (Sell) |
5,282 |
- |
- |
| 2025-11-25 |
Woolson Daniel |
VP, GM-infusion Capital |
Informative Sell |
2,897 |
$152.35 |
$441.36K |
| 2025-11-11 |
Sanzone Virginia Ruth |
VP, General Counsel |
Informative Sell |
930 |
$142.35 |
$132.38K |
| 2025-11-11 |
Finney Elisha W |
Director |
Option Exercise (Sell) |
1,285 |
$103.76 |
$133.33K |
| 2025-09-12 |
Jain Vivek |
Chairman and CEO |
Gift (Given) |
63,641 |
- |
- |
| 2025-08-27 |
Greenberg David C. |
Director |
Informative Buy |
602 |
$126.14 |
$75.94K |
| 2025-08-14 |
Jain Vivek |
Chairman and CEO |
Informative Buy |
2,378 |
$112.12 |
$266.61K |
